Cambridge Investment Research Advisors’s Sharecare, Inc. Class A Common Stock SHCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,200
Closed -$14K 3538
2024
Q2
$14K Sell
10,200
-1,000
-9% -$822 ﹤0.01% 3282
2024
Q1
$9K Buy
11,200
+1,000
+10% +$1K ﹤0.01% 3291
2023
Q4
$11K Hold
10,200
﹤0.01% 3165
2023
Q3
$10K Hold
10,200
﹤0.01% 3114
2023
Q2
$18K Hold
10,200
﹤0.01% 3133
2023
Q1
$14K Hold
10,200
﹤0.01% 3121
2022
Q4
$16K Sell
10,200
-20
-0.2% -$37 ﹤0.01% 3060
2022
Q3
$19K Hold
10,220
﹤0.01% 3006
2022
Q2
$16K Sell
10,220
-150
-1% -$368 ﹤0.01% 3010
2022
Q1
$26K Buy
+10,370
New +$34.1K ﹤0.01% 3112

Other funds holding SHCR

Cambridge Investment Research Advisors's SHCR Position: Q3 2024 in Review

Cambridge Investment Research Advisors sold out of Sharecare, Inc. Class A Common Stock (SHCR) in Q3 2024, closing a stake of 10,200 shares — an estimated $14K sold.

Cambridge Investment Research Advisors first reported a position in SHCR in Q1 2022 and held it in 10 quarters. The position peaked at $26K in Q1 2022. 101 funds tracked by Wall St. Rank hold SHCR as of Q3 2024.

  • Cambridge Investment Research Advisors reported no remaining Sharecare, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,200 Sharecare, Inc. Class A Common Stock shares in Q3 2024, an estimated $14K.
  • Cambridge Investment Research Advisors first reported a position in Sharecare, Inc. Class A Common Stock in Q1 2022 and held it in 10 quarters.
  • Cambridge Investment Research Advisors's Sharecare, Inc. Class A Common Stock position peaked at $26K in Q1 2022.
  • 101 funds tracked by Wall St. Rank held Sharecare, Inc. Class A Common Stock as of Q3 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2024, filed 28 Oct 2024.